Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether consumption of carbonated drinks containing sweeteners affect insulin sensitivity.


Clinical Trial Description

Sweeteners are natural or synthetic sugar substitutes which provide a sweetness taste to drink and food with few or no additional calories. Sweeteners are widely used in commercialized beverages. Despite some debate, no significant toxicity was demonstrated at a reasonable level of consumption (less than 20 cans per day). However little data is available on the metabolic effects of a regular consumption of beverages containing sweeteners. The objective of the study is to evaluate the effect of a regular consumption (twice a day for 12 weeks) of a carbonated drink with sweeteners, in a normal diet, compared with unsweetened sparkling water on insulin sensitivity in healthy normoweight and overweight subjects. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02031497
Study type Interventional
Source Institute For European Expertise in Physiology
Contact
Status Completed
Phase N/A
Start date October 2012
Completion date December 2014

See also
  Status Clinical Trial Phase
Completed NCT01143493 - The Role of Glucocorticoid Receptor SNPs in Receptor Function and Metabolic Disease
Withdrawn NCT01573806 - Pharmacology of Exenatide in Pediatric Sepsis Phase 1/Phase 2
Active, not recruiting NCT00947011 - Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1) Phase 2
Completed NCT00822003 - Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects Phase 1/Phase 2
Completed NCT02237079 - Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM) Phase 4